Please login to the form below

Not currently logged in
Email:
Password:

Alpharma cautious FY07 outlook on falling EPS

Alpharma posts its Q2 FY07 financial results, revealing a diluted EPS of USD 0.30, compared with USD 0.32 in the Q2 FY06

Alpharma, a US-based specialty pharmaceutical company, has posted its Q2 FY07 financial results, revealing a diluted EPS of USD 0.30, compared with USD 0.32 in the Q2 FY06.

Revenue increased 12.7 per cent helped by strong performance by Alpharmaís three businesses. Operating income was USD 17.0m, a fall of USD 6.3m, compared with Q2 FY06 and reflected a USD 11.7m increase in R&D spending to shore up the company's abuse-deterrent pain product platform in its Pharmaceuticals unit.

Operating income decreased USD 8.4m to USD 3.1m in Q2 FY07, compared with operating income of USD 11.5m in Q2 FY06, as a result of increased R&D and SG&A spending. SG&A expenses increased USD 4.4m.

Active pharmaceutical ingredient (API) Q2 revenues increased 16 per cent to reach USD 46.3m, compared with USD 39.8m in Q2 FY06. Excluding currency effects, revenues increased 15 per cent on 2006 levels, driven by increased volumes of vancomycin.

Sales of chronic pain therapy Kadian (morphine extended-release capsules) increased 17 per cent to reach USD 42.6m in Q2 FY07, compared with USD 36.3m in Q2 FY06, due to increased volume, favourable pricing and the launch of the 200mg line extension. Prescriptions for the drug increased seven per cent on Q2 FY06.

The Kadian gains were tempered by reported prescription data in 2006, which included prescriptions related to the company's discontinued voucher programme. Excluding 2006 voucher-related prescriptions, Q2 FY07 Kadian prescriptions grew 11 per cent. Wholesaler inventory levels were below 1.5 months by the end of Q2 FY07.

Alpharma expects its 2007 EPS to be at the lower end of its outlook range of USD 1.25 to USD 1.45. The outlook excludes future business development transactions.

1st August 2007

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics